Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Annals of Biomedical Engineering|November 5, 2024
Mechanical Characterization of Non-degraded Porcine Annulus Fibrosus Material PropertiesJack Seifert, Dennis Maiman, Lance L Frazer, et al.Journal of Biomechanical Engineering|October 27, 2022
Response of Thoraco-Abdominal Tissue in High-Rate CompressionJack Seifert, Jared Koser, Alok S Shah, et al.Annals of Biomedical Engineering|October 25, 2024
Lumbar Spine Orientation Affects Compressive Fracture OutcomeRachel Cutlan, Muhammad Khokhar, Nader Shammout, et al.Journal of Neural Engineering|July 30, 2021
Review of wearable technologies and machine learning methodologies for systematic detection of mild traumatic brain injuriesWilliam Schmid, Yingying Fan, Taiyun Chi, et al.Annals of Biomedical Engineering|June 26, 2024
Investigating the Impact of Blunt Force Trauma: A Probabilistic Study of Behind Armor Blunt Trauma RiskVivek Bhaskar Kote, Lance L Frazer, Zachary S Hostetler, et al.Neurosurgical Focus|February 1, 2021
Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomasNidal B Omar, R Timothy Bentley, David K Crossman, et al.Anticancer Research|November 4, 2021
Large Animal Models of Glioma: Current Status and Future ProspectsWilliam H Hicks, Cylaina E Bird, Mark N Pernik, et al.Frontiers in Surgery|October 2, 2020
The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade GliomasM R Chambers, R Timothy Bentley, David K Crossman, et al.Cancer Research|March 9, 2013
Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicityBrian M Andersen, G Elizabeth Pluhar, Charles E Seiler, et al.Veterinary and Comparative Oncology|May 31, 2023
Establishment and characterization of two novel patient-derived lines from canine high-grade gliomaMorgan S Schrock, Abigail A Zalenski, Miranda M Tallman, et al.Pageof 6